Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection
Open Access
- 1 June 1999
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (6) , 1054-1063
- https://doi.org/10.1038/sj.gt.3300914
Abstract
Replication-deficient adenoviruses are among the most widely used vectors in gene therapy and are also becoming increasingly popular as analytical tools in basic research. However, significant toxicity of these vectors in vivo has been reported. Here, we show that in an in vitro setting, first generation adenoviruses lead to growth retardation, prolongation of the G2/M phase and induction of apoptosis if applied at a high multiplicity of infection (MOI). These findings were obtained in p53-deficient hepatocytes, derived from knock-out mice (A2 cells) and in several tumor cell lines containing wild-type (wt) or mutant p53. Apoptosis induction was correlated with increased levels of p53 and bax proteins and it was stronger in cells containing wt p53 as compared with cells lacking functional p53. Apoptosis was highly dependent on the MOI used with marked effects starting at an MOI twice as high as needed for 100% gene transfer. Expression of the adenoviral E4 ORF6 gene as well as adenoviral replication were detected in all cell lines infected with first generation adenovirus. Apoptosis could be considerably reduced but not abrogated by UV inactivation of adenovirus, which indicates proapoptotic effects caused by the infection event as well as by residual adenoviral gene expression or adenoviral replication. First generation adenoviruses apparently display proapoptotic activity if used at higher MOIs, which may be of relevance when these vectors are used as analytical or gene therapeutic tools.Keywords
This publication has 23 references indexed in Scilit:
- Selective extraction of polyoma DNA from infected mouse cell culturesPublished by Elsevier ,2004
- Recombinant E1-Deleted Adenovirus-Mediated Gene Therapy for Cancer: Efficacy Studies with p53 Tumor Suppressor Gene and Liver Histology in Tumor Xenograft ModelsHuman Gene Therapy, 1998
- High adenoviral loads stimulate NFκB-dependent gene expression in human vascular smooth muscle cellsGene Therapy, 1998
- Effect of Adenoviral Vector Infection on Cell Proliferation in Cultured Primary Human Airway Epithelial CellsHuman Gene Therapy, 1995
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994
- Delayed Morbidity and Mortality of Albumin/SV40 T-Antigen Transgenic Mice after Insertion of an α-Fetoprotein/Herpes Virus Thymidine Kinase Transgene and Treatment with GanciclovirHuman Gene Therapy, 1994
- Assessment of Recombinant Adenoviral Vectors for Hepatic Gene TherapyHuman Gene Therapy, 1993
- Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53Experimental Cell Research, 1992
- Widespread long-term gene transfer to mouse skeletal muscles and heart.Journal of Clinical Investigation, 1992
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992